Xtrackers MSCI Global SDG 3 Good Health UCITS ETF (GB:XDG3) Price & Chart
GB:XDG3 ETF Chart & Stats
- Day’s Range
- $40.79 - $40.79
- 52-Week Range
- $32.92 - $41.48
- Previous Close
- $41.32
- Volume
- 10
- Average Volume (3M)
- 354
- AUM
- 29.33M
- NAV
- 41.14
- Expense Ratio
- 0.35%
- Holdings Count
- 116
- Beta
- 0.86
- Inception Date
- Jan 18, 2023
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 717,870
- Standard Deviation
- N/A
ETF Overview
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF
The Xtrackers MSCI Global SDG 3 Good Health UCITS ETF, with the ticker GB:XDG3, is a specialized investment vehicle designed to provide exposure to the global healthcare sector. This ETF focuses on companies that are aligned with Sustainable Development Goal 3 (SDG 3) – ensuring healthy lives and promoting well-being for all at all ages. As a sector-focused, broad-based niche fund, it offers investors a unique opportunity to invest in a diverse range of healthcare companies that are committed to advancing global health initiatives. The Xtrackers MSCI Global SDG 3 Good Health UCITS ETF carefully selects its holdings from a universe of companies that demonstrate strong potential for innovation and growth within the healthcare industry. This ETF not only allows investors to tap into the financial potential of the healthcare sector but also to align their portfolios with sustainable development priorities, making it an attractive option for socially-conscious investors seeking both impact and returns.
GB:XDG3 ETF FAQ
What was GB:XDG3’s price range in the past 12 months?
What is the AUM of GB:XDG3?
Is GB:XDG3 overvalued?
How many shares outstanding does GB:XDG3 have?
GB:XDG3 ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| TMOThermo Fisher Scientific | 4.98% |
| DHRDanaher Corporation | 4.91% |
| ABBVAbbvie | 4.85% |
| GILDGilead Sciences | 4.65% |
| LLYEli Lilly And Company | 4.61% |
| AMGNAmgen Inc | 4.57% |
| JNJJohnson & Johnson | 4.42% |
| MRKMerck & Company | 4.37% |
| VRTXVertex Pharmaceuticals Inc. | 4.04% |
| SYKStryker Corp | 3.73% |
| Total | 45.13% |